Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-045137
Filing Date
2024-11-13
Accepted
2024-11-13 16:15:53
Documents
59
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 995755
2 ex4-14.htm EX-4.14 122479
3 ex31-1.htm EX-31.1 15568
4 ex31-2.htm EX-31.2 15551
5 ex32-1.htm EX-32.1 6831
6 ex32-2.htm EX-32.2 6816
  Complete submission text file 0001493152-24-045137.txt   4797855

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE rnxt-20240930.xsd EX-101.SCH 34699
8 XBRL CALCULATION FILE rnxt-20240930_cal.xml EX-101.CAL 34767
9 XBRL DEFINITION FILE rnxt-20240930_def.xml EX-101.DEF 141291
10 XBRL LABEL FILE rnxt-20240930_lab.xml EX-101.LAB 306708
11 XBRL PRESENTATION FILE rnxt-20240930_pre.xml EX-101.PRE 235771
61 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 665439
Mailing Address 333 W. SANTA CLARA STREET, SUITE 900 SAN JOSE CA 95110
Business Address 333 W. SANTA CLARA STREET, SUITE 900 SAN JOSE CA 95110 408-800-2649
RenovoRx, Inc. (Filer) CIK: 0001574094 (see all company filings)

EIN.: 271448452 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40738 | Film No.: 241454482
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)